biomedicina slovenica


pr=Castiglione-Gertsch : 21

  1. Gruber G; Cole BF; Castiglione-Gertsch M; Holmberg SB; Lindtner J; Golouh R; Collins J; Crivellari D; Thurlimann B; Simoncini E; Fey MF; Gelber RD; Coates AS; Price KN; Goldhirsch A; Viale G; Gusterson BA; Eržen D; Čufer T; Majdič E; Štabuc B; Lamovec J; Jančar J; Vrhovec I; Kramberger M; Novak J; Naglas M; Senčar M; Červek J; Šebek S; Cerar O; Plesničar A; Zakotnik B
    Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer
    2008
  2. Thurlimann Beat; Price Karen N; Gelber Richard D; Holmberg Stig B; Crivellari Diana; Colleoni Marco; Collins John; Forbes John F; Castiglione-Gertsch Monica; Lindtner J; Eržen D; Čufer T; Červek J; Cerar O; Zakotnik B; Majdič E; Golouh R; Lamovec J; Jančar J; Vrhovec I; Kramberger M
    Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93
    2009
  3. Pagani O; Gelber S; Simoncini E; Castiglione-Gertsch M; Price KN; Gelber RD; Holmberg SB; Crivellari D; Lindtner J; Čufer T
    Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93
    2009
  4. Colleoni M; Li SZ; Gelber Richard D; Coates Alan S; Castiglione-Gertsch M; Price Karen; Lindtner Jurij; Rudenstam Carl-Magnus; Crivellari Diana; Collins Joseph; Pagani Olivia; Simoncini E.; Thürlimann Beat; Murray Elizabeth; Forbes John Alexander; Eržen Darja; Holmberg Stig B.; Veronesi A.; Goldhirsch Aron; Plesničar Andrej; Majdič Elga; Štabuc Borut; Golouh Rastko; Lamovec Janez; Jančar Janez; Vrhovec Ivan; Kramberger Marta; Novak Janez; Naglas M; Senčar Mojca; Červek Jožica; Šebek Slava; Cerar Olga; Čufer Tanja
    Timing of CMF chemotherapy in combination with tamoxifen in postmenopausal women with breast cancer
    2005
  5. Gruber Guenther; Bonetti Marco; Nasi Laura M; Price Karen; Castiglione-Gertsch Monica; Rudenstam Carl-Magnus; Holmberg Stig B; Lindtner Jurij; Golouh Rastko; Collins John
    Prognostic value of extracapsular tumor spread for locoregional control in premenopausal patients with node-positive breast cancer treated with classical cyclophosphamide, methotrexate, and fluorouracil: long-term observations from international breast cancer study group trial VI
    2005
  6. Gruber G; Bonetti M; Nasi M; Price K; Castiglione-Gertsch M; Rudenstam C; Holmberg S; Lindtner J; Golouh R; Collins J
    Extracapsular tumor spread (ECS) in premenopausal node-positive breast cancer patients treated with classical CMF: long-term results from IBCSG trial VI
    2004
  7. Trihia Helen; Murray Susan; Price Karen; Gelber Richard D; Golouh Rastko; Goldhirsch Aron; Coates Alan S; Collins John; Castiglione-Gertsch Monica; Gusterson Barry A
    Ki-67 expression in breast carcinoma: its association with grading systems, clinical parameters, and other prognostic factors - a surrogate marker?
    2003
  8. Aebi S; Gelber S; Castiglione-Gertsch M; Gelber RD; Collins J; Thurlimann B; Rudenstam CM; Lindtner J
    Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?
    2000
  9. Colleoni M; Litman HJ; Castiglione-Gertsch M; Sauerbrei W; Gelber RD; Bonetti M; Coates AS; Schumacher M; Bastert G; Lindtner J
    Duration of adjuvant chemotherapy for breast cancer: a joint analysis of two randomised trials investigating three versus six courses of CMF
    2002
  10. Wallgren A; Bonetti M; Gelber RD; Goldhirsch A; Castiglione-Gertsch M; Holmberg SB; Lindtner J
    Risk factors for locoregional recurrence among breast cancer patients: results from International breast cancer study group trials I through VII
    2003
  11. Crivellari Diana; Price Karren; Gelber Richard D; Castiglione-Gertsch Monika; Rudenstam Carl-Magnus; Lindtner Jurij
    Adjuvant endocrine therapy compared with no systemic therapy for elderly women with early breast cancer: 21-year results of International breast cancer study group trial IV
    2003
  12. Colleoni Marco; Gelber Shari; Coates Alan S; Castiglione-Gertsch Monica; Gelber Richard D; Price Karen; Rudenstam Carl-Magnus; Lindtner Jurij; Collins John; Thuerlimann Beat
    Influence of endocrine-related factors on response to perioperative chemotherapy for patients with node-negative breast cancer
    2001
  13. Gelber Shari; Coates Alan A; Goldhirsch Aron; Castiglione-Gertsch Monica; Marini Gianluigi; Lindtner Jurij; Edelmann David Z; Gudgeon Anne; Harvey Vernon; Gelber Richard D
    Effect of pregnancy on overall survival after the diagnosis of early-stage breast cancer
    2001
  14. Castiglione-Gertsch M; Price KN; Nasi ML; Lindtner J; Eržen D; Crivellari D; Veronesi A; Fey M; Pagani O; Collins J
    Is the addition of adjuvant chemotherapy always necessary in node negative (N-) postmenopausal breast cancer patients (Pts) who receive tamoxifen (TAM)?: first results of IBCSG trial IX
    2000
  15. Colleoni Marco; Smith Heather; Castiglione-Gertsch Monica; Gelber Richard D; Sauerbrei Willi; Coates Alan S; Schumacher Martin; Bonetti Marco; Bastert Gunter; Lindtner Jurij
    Duration of adjuvant chemotherapy: a joint analysis of two randomized trails investigating 3 versus 6 courses of cyclophosphamide methotrexate and 5-fluorouracil (CMF) without endocrine treatment
    2000
  16. Colleoni Marco; O'Neill Anne; Goldhirsch Aron; Gelber Richard D; Bonetti Marco; Thuerlimann Beat; Price Karen N; Castiglione-Gertsch Monica; Coates Alan S; Lindtner Jurij
    Identifying breast cancer patients at high risk for bone metastases
    2000
  17. Colleoni Marco; Bonetti Marco; Coates Alan S; Castiglione-Gertsch Monica; Gelber Richard D; Price Karen; Rudenstam Carl-Magnus; Lindtner Jurij; Collins John; Thuerlimann Beat
    Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors
    2000
  18. Crivellari Diana; Bonetti Marco; Castiglione-Gertsch Monica; Gelber Richard D; Rudenstam Carl-Magnus; Thuerlimann Beat; Price Karen N; Coates Alan S; Huerny Christoph; Lindtner Jurij
    Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International breast cancer study group Trial VII
    2000
  19. Hurny Christoph; Bernhard Juerg; Coates Alan; Peterson Harriet F; Castiglione-Gertsch Monica; Gelber Richard D; Rudenstam Carl-Magnus; Collins John; Lindtner Jurij; Goldhirsch Aron; Senn Hans-Joerg
    Responsiveness of a single-item indicator versus a multi-item scale: assessment of emotional well-being in an International adjuvant breast cancer trial
    1996
  20. Colleoni M; Price K; Gelber RD; Castiglione-Gertsch M; Rudenstam CM; Coates A; Thuerlimann B; Lindtner J; Collins J; Goldhirsch A
    Dose-response effect of adjuvant cyclophosphamide, methotrexate, fluorouracil in node-positive breast cancer
    1998
  21. Marini G; Murray S; Goldhirsch A; Gelber RD; Castiglione-Gertsch M; Price KN; Tattersall MHN; Rudenstam C-M; Collins J; Lindtner J
    The effect of adjuvant prednisone combined with CMF on patterns of relapse and occurence of second malignancies in patients with breast cancer
    1996


New search      Comments      Top of page Institute for Biostatistics and Medical Informatics